Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXCL10/CXCR3 Regulation of Ozone-Induced Epithelial Permeability
NCT03599206Phase 1Completed
- Start
- Aug 2019
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms). Primary endpoints: Clara Cell Secretory Protein Level at 21 days and Albumin Level at 21 days. Started Aug 2019; status: completed.
Beyond the preview
Go deeper on NCT03599206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03599206.